Clinical trials
Enrolling by invitation Pulmonary Arterial Hypertension trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
4 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2018 | 1 |
| 2019 | 1 |
| 2021 | 1 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Enrolling by invitation | 4 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AOP Orphan Pharmaceuticals AG | 1 |
| Paragonix Technologies | 1 |
| United Therapeutics | 1 |
| University of Giessen | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Pulmonary Arterial Hypertension | 4 |
| Familial Primary Pulmonary Hypertension | 2 |
| Hypertension, Pulmonary | 2 |
| Lung Diseases | 2 |
| Vascular Diseases | 2 |
| Cardiovascular Diseases | 1 |
| Connective Tissue Diseases | 1 |
| Cystic Fibrosis | 1 |
| Emphysema | 1 |
| Hypertension | 1 |
Trials
Showing 26 to 4 of 4. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.